These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 6299860)
1. Organophosphorous compounds as inhibitors of EBV infection and transformation. Margalith M; Manor D; Goldblum N Dev Biol Stand; 1982; 52():515-26. PubMed ID: 6299860 [TBL] [Abstract][Full Text] [Related]
2. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV. Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633 [TBL] [Abstract][Full Text] [Related]
3. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus. Manor D; Margalith M Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303 [TBL] [Abstract][Full Text] [Related]
4. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV. Margalith M; Manor D; Usieli V; Goldblum N Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504 [No Abstract] [Full Text] [Related]
5. Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid. Lemon SM; Hutt LM; Pagano JS J Virol; 1978 Jan; 25(1):138-45. PubMed ID: 202732 [TBL] [Abstract][Full Text] [Related]
6. On the continuous culturing of B.95-8 cells in the presence of phosphonoacetic acid. Margalith M; Manor D; Goldblum N J Virol Methods; 1980; 1(6):349-54. PubMed ID: 6262340 [TBL] [Abstract][Full Text] [Related]
7. [Studies on transformation of human lymphocytes by Epstein-Barr virus (author's transl)]. Takada K Hokkaido Igaku Zasshi; 1980 Sep; 55(5):447-70. PubMed ID: 6263773 [TBL] [Abstract][Full Text] [Related]
8. Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir. Keever-Taylor CA; Behn B; Konings S; Orentas R; Davies B; Margolis D Cytotherapy; 2003; 5(4):323-35. PubMed ID: 12944239 [TBL] [Abstract][Full Text] [Related]
9. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides. Meerbach A; Friedrichs C; Thust R; Wutzler P Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells. Chen C; Johnston TD; Reddy KS; Merrick JC; Mastrangelo M; Ranjan D J Surg Res; 2001 Oct; 100(2):166-70. PubMed ID: 11592787 [TBL] [Abstract][Full Text] [Related]
11. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit]. Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576 [TBL] [Abstract][Full Text] [Related]
12. Sensitivity of the transforming and replicative functions of Epstein--Barr virus to inhibition by phosphonoacetate. Rickinson AB; Epstein MA J Gen Virol; 1978 Aug; 40(2):409-20. PubMed ID: 211188 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the expression of Epstein-Barr virus antigens in vitro by Chinese medicine compound "Dongxia wan". Huang P; Deng H; Zhao M Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):128-30. PubMed ID: 11503041 [TBL] [Abstract][Full Text] [Related]
14. [Influence of selenium-rich rice on transformation of umbilical blood B lymphocytes by Epstein-Barr virus and Epstein-Barr virus early antigen expression]. Jian SW; Mei CE; Liang YN; Li D; Chen QL; Luo HL; Li YQ; Cai TY Ai Zheng; 2003 Jan; 22(1):26-9. PubMed ID: 12561431 [TBL] [Abstract][Full Text] [Related]
15. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma. Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420 [TBL] [Abstract][Full Text] [Related]
16. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate. Margalith M; Falk H; Panet A Mol Cell Biochem; 1982 Mar; 43(2):97-103. PubMed ID: 6178013 [TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine to Epstein-Barr virus producer and nonproducer lymphoma cells in culture. Margalith M; Manor D; Cohen T Cancer Biochem Biophys; 1983; 6(3):189-96. PubMed ID: 6303555 [TBL] [Abstract][Full Text] [Related]
19. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines. Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865 [TBL] [Abstract][Full Text] [Related]
20. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]